243.01
price down icon3.67%   -9.26
after-market After Hours: 243.01
loading
Penumbra Inc stock is traded at $243.01, with a volume of 694.06K. It is down -3.67% in the last 24 hours and down -3.06% over the past month. Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
See More
Previous Close:
$252.27
Open:
$249.74
24h Volume:
694.06K
Relative Volume:
1.37
Market Cap:
$9.41B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
229.25
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
+4.25%
1M Performance:
-3.06%
6M Performance:
-8.97%
1Y Performance:
+41.90%
1-Day Range:
Value
$241.24
$251.98
1-Week Range:
Value
$225.48
$261.81
52-Week Range:
Value
$163.63
$310.00

Penumbra Inc Stock (PEN) Company Profile

Name
Name
Penumbra Inc
Name
Phone
(510) 995-2486
Name
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Name
Employee
4,500
Name
Twitter
@penumbrainc
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
PEN's Discussions on Twitter

Compare PEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
PEN
Penumbra Inc
243.01 9.84B 1.24B 42.23M 150.33M 1.06
Medical Devices icon
ABT
Abbott Laboratories
127.29 219.63B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.41 155.22B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
377.79 150.09B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
89.34 115.62B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
79.33 46.52B 5.69B 4.15B 623.10M 6.95

Penumbra Inc Stock (PEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-14-25 Initiated BofA Securities Buy
Jan-21-25 Initiated UBS Buy
Dec-17-24 Initiated Oppenheimer Outperform
Dec-11-24 Upgrade Wells Fargo Equal Weight → Overweight
Sep-18-24 Initiated Stifel Buy
Sep-03-24 Initiated Leerink Partners Outperform
Jul-31-24 Downgrade Citigroup Buy → Neutral
Jul-31-24 Downgrade Wells Fargo Overweight → Equal Weight
Feb-23-24 Downgrade JP Morgan Overweight → Neutral
Sep-06-23 Initiated Morgan Stanley Equal-Weight
Jul-19-23 Initiated Robert W. Baird Outperform
Mar-29-23 Downgrade Needham Buy → Hold
Jan-30-23 Initiated Piper Sandler Overweight
Nov-04-22 Upgrade Citigroup Neutral → Buy
Oct-12-22 Initiated Jefferies Buy
Oct-05-22 Downgrade Citigroup Buy → Neutral
Sep-09-22 Upgrade Needham Hold → Buy
Jul-18-22 Initiated RBC Capital Mkts Outperform
Apr-19-22 Initiated Deutsche Bank Buy
Mar-08-22 Initiated Needham Hold
Sep-16-21 Initiated Truist Buy
Jun-04-21 Upgrade BTIG Research Neutral → Buy
Dec-16-20 Downgrade BTIG Research Buy → Neutral
Oct-07-20 Resumed Canaccord Genuity Buy
Sep-29-20 Initiated BTIG Research Buy
Sep-08-20 Downgrade BofA Securities Buy → Neutral
Mar-05-20 Initiated Citigroup Buy
Jun-13-19 Reiterated BofA/Merrill Buy
May-30-19 Upgrade JP Morgan Neutral → Overweight
May-21-19 Initiated William Blair Outperform
Oct-29-18 Resumed BofA/Merrill Buy
Oct-08-18 Initiated RBC Capital Mkts Outperform
Feb-21-18 Initiated William Blair Outperform
Jan-02-18 Downgrade JP Morgan Overweight → Neutral
Nov-30-15 Reiterated Canaccord Genuity Buy
Oct-13-15 Initiated Wells Fargo Outperform
View All

Penumbra Inc Stock (PEN) Latest News

pulisher
11:59 AM

What are the latest earnings results for Penumbra Inc.Pre Market Planner For Beginners - jammulinksnews.com

11:59 AM
pulisher
06:53 AM

Results: Penumbra, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st

06:53 AM
pulisher
Jul 31, 2025

UBS Analyst Increases Penumbra's Price Target to $335 - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference - Eastern Progress

Jul 31, 2025
pulisher
Jul 31, 2025

Should You Invest in Penumbra (PEN)? - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Penumbra Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Is it the right time to buy Penumbra Inc. stockStock Strategy Tracker For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Penumbra Inc. Reports Strong Q2 Earnings with Growth in U.S. Thrombectomy - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra Surges 11.9% on Q2 Earnings Beat and Margin Expansion as $300M Volume Pushes It to 407th Trading Rank - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra, Inc. To Present At The Canaccord Genuity 45th Annual Growth Conference - Barchart.com

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra (PEN) Shares Skyrocket, What You Need To Know - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra stock price target lowered to $325 at RBC Capital on margin outlook - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra: Truist Securities maintains a 'Buy' Rating, The Target Price is $310 - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra stock price target raised to $335 from $330 at UBS on solid growth - Investing.com

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra price target raised to $335 from $330 at UBS - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

Why Did Penumbra Stock Soar 14.46%? - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

S&P 500 Futures Climb in Premarket Trading; Penumbra, Marvell Technology Lead - Barron's

Jul 30, 2025
pulisher
Jul 30, 2025

Why Penumbra Inc. stock attracts strong analyst attentionScalable Portfolio Growth Suggestions Released - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Reve - GuruFocus

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra outlines 13% to 15% revenue growth target for 2025 as thrombectomy adoption accelerates - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

Penumbra, Inc. Reports Strong Q2 2025 Results - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Penumbra 2025 Q2 Earnings Strong Performance as Net Income Swings to Profit - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra's Q2 2025: Dissecting Contradictions on Thunderbolt FDA Review, Revenue Guidance, and Market Dynamics - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra Lifts Revenue Forecast As US Demand Climbs - Finimize

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra, Inc. shares rise 11.44% after-hours after Q2 earnings and revenue beat expectations. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra, Inc. shares rise 9.46% after-hours after reporting Q2 Non-GAAP earnings and revenue growth. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Founder-led focus meets demographic tailwinds: A decade-long runway - Livewire Markets

Jul 29, 2025
pulisher
Jul 29, 2025

Earnings call transcript: Penumbra Inc. beats Q2 2025 estimates - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Earnings call transcript: Penumbra Inc. beats Q2 2025 estimates By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra (PEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra’s (NYSE:PEN) Q2: Strong Sales, Stock Soars - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra: Q2 Earnings Snapshot - San Antonio Express-News

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra shares surge as thrombectomy leader beats Q2 expectations - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra Inc earnings beat by $0.03, revenue topped estimates - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra, Inc. Reports Second Quarter 2025 Financial Results - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra Earnings: VTE Sales Soar 42%, Medical Device Giant Lifts Revenue Forecast to $1.37B - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

Is It Too Early to Call Recovery in Penumbra Inc.Wealth Building Stock Market Ideas Based on Momentum - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Penumbra Inc. Sees Spike in Bullish Option FlowLow Drawdown Real Time Trading Tips Shared - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Penumbra Inc. in the next 12 monthsDaily Trading Report For Smart Trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Penumbra Inc. company’s balance sheetValue Investing Opportunities For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Penumbra's CEO Stock Sale: Strategic Liquidity or Market Signal? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

What are Penumbra Inc. company’s key revenue driversPhenomenal capital appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Penumbra Inc.Unmatched profit growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Penumbra (PEN) Earnings Report: Is This Medical Innovator Poised to Sustain Its Earnings Beat Momentum? - AInvest

Jul 27, 2025
pulisher
Jul 27, 2025

Penumbra (PEN) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Penumbra Inc. stock price move sharplyDiscover high-impact stocks for your portfolio - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Penumbra Inc. stockLightning-fast capital gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Penumbra Inc. a growth stock or a value stockConsistent high-yield stocks - jammulinksnews.com

Jul 27, 2025

Penumbra Inc Stock (PEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Penumbra Inc Stock (PEN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Elsesser Adam
CEO and President
Jul 23 '25
Sale
233.16
16,150
3,765,574
146,258
$284.91
price down icon 1.21%
medical_devices STE
$226.87
price up icon 0.17%
medical_devices PHG
$26.46
price up icon 0.99%
$79.28
price down icon 1.84%
$69.85
price down icon 2.06%
medical_devices EW
$79.33
price up icon 0.03%
Cap:     |  Volume (24h):